HIPS Board Member, Dr. Andrea Lopez joins Drug Policy Alliance for a discuss on harm reduction and essential activities during a pandemic. The COVID-19 environment complicates access to harm reduction services, but also provides new opportunities for innovation and advocacy at a time when these services are needed more than ever. Join advocates and allies in the drug policy reform and harm reduction movements to explore how COVID has impacted harm reduction services and practices in the community, examine novel models that could be replicated, discussing harm reduction in the context of mutual aid, and strategies to improve, and expand access in this moment. Join Zoom here.
Drug Policy Alliance COVID Discussion Series: New Frontiers: Drug Use, Harm Reduction, and Essential Services in the Time of COVID-19 featuring HIPS Board Member, Dr. Andrea Lopez
Article by Jessica Martinez, HIPS Methamphetamine Services Specialist